BioCentury
ARTICLE | Clinical News

BIND-014: Completed Phase II enrollment

February 8, 2016 8:00 AM UTC

Bind completed enrollment of about 40 patients in the squamous histology cohort of the open-label, international Phase II iNSITE 1 trial evaluating 60 mg/kg IV BIND-014 every 3 weeks. In December, the...